Current status of prognostic factors in patients with metastatic renal cell carcinoma
Author:
Affiliation:
1. Department of Urology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
Publisher
Wiley
Subject
Urology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.13956
Reference122 articles.
1. Cancer statistics, 2018
2. Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER–Medicare Database Analysis
3. Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
4. Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor;Urologic Oncology: Seminars and Original Investigations;2022-10
2. Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma;Current Urology;2022-08-02
3. Prognostic model of upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors and/or targeted agents;International Urology and Nephrology;2022-03-22
4. Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer;Future Oncology;2021-10
5. Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor;Current Urology;2021-09-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3